TY  - JOUR
AU  - Ben-Baruch, Adit
TI  - Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy.
JO  - Frontiers in immunology
VL  - 13
SN  - 1664-3224
CY  - Lausanne
PB  - Frontiers Media
M1  - DKFZ-2025-02460
SP  - 903679
PY  - 2022
N1  - #DKFZ-MOST-Ca187#
KW  - Humans
KW  - Neoplasms: drug therapy
KW  - Receptors, Tumor Necrosis Factor, Type I
KW  - Receptors, Tumor Necrosis Factor, Type II
KW  - Tumor Necrosis Factor-alpha
KW  - TNFR1 (Other)
KW  - TNFR2 (Other)
KW  - cancer (Other)
KW  - personalized therapy (Other)
KW  - tumor necrosis factor α/TNFα (Other)
KW  - Receptors, Tumor Necrosis Factor, Type I (NLM Chemicals)
KW  - Receptors, Tumor Necrosis Factor, Type II (NLM Chemicals)
KW  - Tumor Necrosis Factor-alpha (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:35663982
C2  - pmc:PMC9157545
DO  - DOI:10.3389/fimmu.2022.903679
UR  - https://inrepo02.dkfz.de/record/306231
ER  -